Tweet
Does anyone have a VCF formatted file for the COSMIC database, or do I need to spend some time to write one?
-
-
I'm looking for a tool to do the conversion (COSMIC to VCF). Did you come up with any? -
I suspect that this is going to be one of those 'everyone rolls their own' situation. I really wish they would just release COSMIC in VCF format..Comment
-
In a developmental tool by GATK, one of the input files is a cosmic vcf see here https://confluence.broadinstitute.or...GATools/MuTect. I just emailed the group to find out where to download this file. I'll post if I here anything back.Comment
-
Yes I'm aware that exists, but I'm not sure I can use it within the terms of the licence agreement for MuTect accessComment
-
We generated a conversion script to so I could use GATK annotator to mark cosmic positions in a VCF. I can post the file on my site (http://www.keatslab.org/resources/ngs-tools/ngs-scripts). You are free to use it. It works in my hands though I didn't line by line verify that no mutations were skipped.Last edited by Jon_Keats; 02-09-2012, 08:39 AM.Comment
-
Thanks John. Do you know if it uses only the positional information for annotation or the position combined with the type/alternate of variant?Comment
-
-
It's up at the update link now. For GATK annotator is only use the position information not coding changes. In my pipeline we annotate the VCF then use SNPeff to call coding changes. No sense annotating the coding changes when SNPeff redoes it each time in 1-2 minutesComment
-
Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment